Fleetwood Onsite Conference Recording - Conference presentation capture Contact  |  My Account  |  Cart Contents  |  Checkout   
  Home » OESO - World Organization for Specialized Studies on Diseases of the Esophagus » 12th OESO World Conference - 2013 » Sessions »

Previous Product  Product 7 of 39  Next Product   From: Sessions

 
 Grand Forum 6 - Personalized medicine. Strategies for cancer prevention $10.00   
Select Format:

Includes all of these presentations from this session:

# Presentation Speaker
1 Keynote: Can molecularly-based strategies improve esophageal cancer-related outcomes in at-risk populations? E.T. Hawk (Houston)
2 Access to molecular testing and targeted therapies in France F. Calvo (NCA, Paris)
3 Which agents are most promising for the clinic now? Selenium, NSAIDs, China-based trials, SCCA P. Taylor (Bethesda)
4 Which agents are most promising for the clinic now? COXIBs, PPIs, phase 2 trials, Barrett?s/adenoCA G. Triadafilopoulos (Stanford)
5 Which agents are most promising for the clinic now? Dietary modification A. Umar (NCI, Bethesda)
6 Which agents are most promising for the clinic now? Statins in the chemoprevention and treatment of esophageal cancer - Data from observational cohort studies L. Alexandre (Norfolk)
7 Which populations are in need of, or might benefit from, preventive strategies? Barrett?s/adenoCA Y. Romero (Rochester, MN)
8 How might we identify the most promising targets/agents going forward? Preclinical systems, new targets/agents, preclinical testing N. Buttar (Rochester, MN)
9 How might we identify the most promising targets/agents going forward? Genomic/epigenomic analyses A. Umar (NCI, Bethesda)
10 How might we identify the most promising targets/agents going forward? Biomarkers, potential targets in BE/adenoCA D. Kandioler (Vienna)

 






 Copyright © 2021 Fleetwood Onsite Conference Recording


Fleetwood Facebook Page Follow us on Twitter Fleetwood on YouTube